��«Ӱҵ

Journal articles

• Bauer CS, Webster CP, Shaw AC, Kok JR, Castelli LM, Lin Y-H, Smith EF, Illanes-Álvarez F, Higginbottom A, Shaw PJ , Azzouz M et al (2022) . Frontiers in Cellular Neuroscience, 16.
• Marchi PM, Marrone L, Brasseur L, Coens A, Webster CP, Bousset L, Destro M, Smith EF, Walther CG, Alfred V , Marroccella R et al (2022) . Life Science Alliance, 5(9), e202101276-e202101276.
• Bauer CS, Webster CP, Shaw AC, Kok JR, Castelli LM, Lin Y-H, Smith EF, Illanes-Álvarez F, Higginbottom A, Shaw PJ , Azzouz M et al (2022) Loss of TMEM106B exacerbates C9ALS/FTD DPR pathology by disrupting autophagosome maturation. Frontiers in cellular neuroscience, 16.
• Derrick CJ, Pollitt EJG, Sevilla Uruchurtu AS, Hussein F, Grierson AJ & Noël ES (2021) . Development.
• Keerie A, Brown-Wright H, Kirkland I, Grierson A, Alix JJP, Holscher C & Mead RJ (2021) . Scientific Reports, 11.
• Ciervo Y, Gatto N, Allen C, Grierson A, Ferraiuolo L, Mead RJ & Shaw PJ (2021) . Molecular Therapy — Methods & Clinical Development, 21, 413-433.
• Gibson JF, Prajsnar TK, Hill CJ, Tooke AK, Serba JJ, Tonge RD, Foster SJ, Grierson AJ, Ingham PW, Renshaw SA & Johnston SA (2020) . Autophagy.
• Fernandes JG, Franco NH, Grierson AJ, Hultgren J, Furley AJW & Olsson IAS (2019) . BMJ Open Science, 3(1).
• Webster CP, Smith EF, Grierson AJ & De Vos K (2016) . Small GTPases.
• Webster CP, Smith EF, Bauer CS, Moller A, Hautbergue GM, Ferraiuolo L, Myszczynska MA, Higginbottom A, Walsh MJ, Whitworth AJ , Kaspar BK et al (2016) . EMBO Journal, 35(15), 1656-1676.
• Lukashchuk V, Lewis KE, Coldicott I, Grierson AJ & Azzouz M (2016) . Molecular Therapy - Methods and Clinical Development, 3.
• Allen SP, Duffy LM, Shaw PJ & Grierson AJ (2015) . Neurobiology of Aging, 36(10), 2893-2903.
• Bennett EJ, Mead RJ, Azzouz M, Shaw PJ & Grierson AJ (2014) . PLoS ONE, 9(9), e107918-e107918.
• Grant RA, Sharp PS, Kennerley AJ, Berwick J, Grierson A, Ramesh T & Prescott TJ (2014) . Behav Brain Res, 259, 274-283.
• Allen SP, Rajan S, Duffy L, Mortiboys H, Higginbottom A, Grierson AJ & Shaw PJ (2014) . Neurobiol Aging, 35(6), 1499-1509.
• Richardson K, Allen SP, Mortiboys HJ, Grierson AJ, Wharton SB, Ince PG, Shaw PJ & Heath PR (2013) . Plos One, 6(8), e68256-e68256.
• Mead RJ, Higginbottom A, Allen SP, Kirby J, Bennett E, Barber SC, Heath PR, Coluccia A, Patel N, Gardner I , Brancale A et al (2013) . Free Radic Biol Med, 61, 438-452.
• Hewamadduma CAA, Grierson AJ, Ma TP, Pan L, Moens CB, Ingham PW, Ramesh T & Shaw PJ (2013) . Hum Mol Genet, 22(12), 2376-2386.
• Chapman AL, Bennett EJ, Ramesh TM, De Vos KJ & Grierson AJ (2013) . PLoS One, 8(6), e67276.
• Hameed A, Bennett E, Ciani B, Hoebers LPC, Milner R, Lawrie A, Francis SE & Grierson AJ (2013) . PLoS One, 8(1), e54636.
• Rocca RA, Magoon G, Reynolds DF, Krahn T, Tilroe VO, Op den Velde Boots PM & Grierson AJ (2012) . PLoS ONE, 7(7).
• Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M & Shaw PJ (2011) . Nat Rev Neurol, 7(11), 616-630.
• Mead RJ, Bennett EJ, Kennerley AJ, Sharp P, Sunyach C, Kasher P, Berwick J, Pettmann B, Battaglia G, Azzouz M , Grierson A et al (2011) . PLoS One, 6(8), e23244.
• Duffy LM, Chapman AL, Shaw PJ & Grierson AJ (2011) . Neuropathol Appl Neurobiol, 37(4), 336-352.
• Kasher PR, Namavar Y, van Tijn P, Fluiter K, Sizarov A, Kamermans M, Grierson AJ, Zivkovic D & Baas F (2011) . Hum Mol Genet, 20(8), 1574-1584.
• Mahmood QA, Whitworth A & Grierson A (2010) Role of Mitochondrial Dynamics in Neurodegeneration. J NEUROGENET, 24, 64-65.
• Valori CF, Ning K, Wyles M, Mead RJ, Grierson AJ, Shaw PJ & Azzouz M (2010) . Sci Transl Med, 2(35), 35ra42.
• Cox LE, Ferraiuolo L, Goodall EF, Heath PR, Higginbottom A, Mortiboys H, Hollinger HC, Hartley JA, Brockington A, Burness CE , Morrison KE et al (2010) . PLoS One, 5(3), e9872.
• Hewamadduma C, McDermott C, Kirby J, Grierson A, Panayi M, Dalton A, Rajabally Y & Shaw P (2009) . Neurogenetics, 10(2), 105-110.
• Kasher PR, De Vos KJ, Wharton SB, Manser C, Bennett EJ, Bingley M, Wood JD, Milner R, McDermott CJ, Miller CCJ , Shaw PJ et al (2009) . J Neurochem, 110(1), 34-44.
• Zhan L, Liu B, Jose-Lafuente M, Chibalina MV, Grierson A, Maclean A & Nasir J (2008) . Eur J Neurosci, 27(7), 1626-1633.
• De Vos KJ, Grierson AJ, Ackerley S & Miller CCJ (2008) . Annu Rev Neurosci, 31, 151-173.
• De Vos KJ, Chapman AL, Tennant ME, Manser C, Tudor EL, Lau K-F, Brownlees J, Ackerley S, Shaw PJ, McLoughlin DM , Shaw CE et al (2007) . Hum Mol Genet, 16(22), 2720-2728.
• Sathasivam S, Grierson AJ & Shaw PJ (2005) . Neuropathol Appl Neurobiol, 31(5), 467-485.
• Connell JW, Rodriguez-Martin T, Gibb GM, Kahn NM, Grierson AJ, Hanger DP, Revesz T, Lantos PL, Anderton BH & Gallo J-M (2005) . Brain Res Mol Brain Res, 137(1-2), 104-109.
• De Vos KJ, Allan VJ, Grierson AJ & Sheetz MP (2005) . Curr Biol, 15(7), 678-683.
• Ackerley S, Grierson AJ, Banner S, Perkinton MS, Brownlees J, Byers HL, Ward M, Thornhill P, Hussain K, Waby JS , Anderton BH et al (2004) . Mol Cell Neurosci, 26(2), 354-364.
• Saha AR, Hill J, Utton MA, Asuni AA, Ackerley S, Grierson AJ, Miller CC, Davies AM, Buchman VL, Anderton BH & Hanger DP (2004) . J Cell Sci, 117(Pt 7), 1017-1024.
• McDermott CJ, Grierson AJ, Wood JD, Bingley M, Wharton SB, Bushby KMD & Shaw PJ (2003) . Ann Neurol, 54(6), 748-759.
• Wharton SB, McDermott CJ, Grierson AJ, Wood JD, Gelsthorpe C, Ince PG & Shaw PJ (2003) . J Neuropathol Exp Neurol, 62(11), 1166-1177.
• Ackerley S, Thornhill P, Grierson AJ, Brownlees J, Anderton BH, Leigh PN, Shaw CE & Miller CCJ (2003) . J Cell Biol, 161(3), 489-495.
• Grierson AJ & Shaw PJ (2003) . Blue Books of Practical Neurology, 28(C), 237-257.
• Brownlees J, Ackerley S, Grierson AJ, Jacobsen NJO, Shea K, Anderton BH, Leigh PN, Shaw CE & Miller CCJ (2002) . Hum Mol Genet, 11(23), 2837-2844.
• Menzies FM, Grierson AJ, Cookson MR, Heath PR, Tomkins J, Figlewicz DA, Ince PG & Shaw PJ (2002) . J Neurochem, 82(5), 1118-1128.
• Gibb G, Hanger D, Anderton B, Connell J, Grierson A, De Silva R & Revesz T (2002) Comparision of tau protein expression in AD, FTDP-17, PSP and Pick's disease. NEUROBIOL AGING, 23(1), S505-S505.
• Miller CCJ, Ackerley S, Brownlees J, Grierson AJ, Jacobsen NJO & Thornhill P (2002) . Cell Mol Life Sci, 59(2), 323-330.
• Grierson AJ, Shaw CE & Miller CC (2001) . Biochim Biophys Acta, 1536(1), 13-20.
• Grierson AJ, Johnson GV & Miller CC (2001) . Neurosci Lett, 298(1), 9-12.
• Standen CL, Brownlees J, Grierson AJ, Kesavapany S, Lau KF, McLoughlin DM & Miller CC (2001) . J Neurochem, 76(1), 316-320.
• Ackerley S, Grierson AJ, Brownlees J, Thornhill P, Anderton BH, Leigh PN, Shaw CE & Miller CC (2000) . J Cell Biol, 150(1), 165-176.
• Utton MA, Killick R, Grierson A, Ackerly S, Lovestone S & Miller C (2000) . Neurobiology of Aging, 21, 113-113.
• Grierson AJ, Mootoosamy RC & Miller CC (1999) . Neurosci Lett, 277(1), 9-12.
• Grierson AJ (1999) Corrigendum: An integrated map of chromosome 18 CAG trinucleotide repeat loci (European Journal of Human Genetics (1999) 7 (12-19)). European Journal of Human Genetics, 7(8), 944.
• Grierson AJ, van Groenigen M, Groot NP, Lindblad K, Hoovers JM, Schalling M, de Belleroche J & Baas F (1999) . Eur J Hum Genet, 7(1), 12-19.
• Meijerink PH, Yanakiev P, Zorn I, Grierson AJ, Bikker H, Dye D, Kalaydjieva L & Baas F (1998) . Eur J Biochem, 254(2), 297-303.
• Guidato S, McLoughlin DM, Grierson AJ & Miller CC (1998) . J Neurochem, 70(1), 335-340.
• Grierson AJ, Hodgkins MA, Hancock BW, Goepel JR, Royds J & Goyns MH (1996) . Leuk Lymphoma, 23(3-4), 353-363.
• Lorigan PC, Grierson AJ, Goepel JR, Coleman RE & Goyns MH (1996) . Cancer Lett, 104(1), 27-30.
• Grierson A, van Groenigen M & Baas F (1996) . Psychiatric Genetics, 6(3), 148-148.
• Grierson AJ, Hammond DW, Goepel JR, Hancock BW & Goyns MH (1994) . Ann Oncol, 5 Suppl 1, 47-50.
• Grierson A (1928) . Public Administration, 6(3), 211-220.
• Bauer CS, Cohen RN, Sironi F, Livesey MR, Gillingwater TH, Highley JR, Fillingham DJ, Coldicott I, Smith EF, Gibson YB , Webster CP et al () . Acta Neuropathologica.
• Łysyganicz PK, Pooranachandran N, Liu X, Adamson KI, Zielonka K, Elworthy S, van Eeden FJ, Grierson AJ & Malicki JJ () . Frontiers in Cell and Developmental Biology, 9.
• Rocca RA, Magoon G, Reynolds DF, Krahn T, Tilroe VO, Op den Velde Boots PM & Grierson AJ () . PLoS ONE, 7(8).
• Grierson A, Sardinia F, Pisciottani A, Ferrara M, Valente D, Casella M, Crescenzi M, Peschiaroli A, Casali C, Soddu S & Rinaldo C () Spastin recovery in hereditary spastic paraplegia by preventing neddylation-dependent degradation. Life Science Alliance.

Chapters

• Miller CCJ, Ackerley S, Brownlees J, Grierson AJ & Thornhill P () , Neuroinflammation (pp. 089-097). Humana Press

Conference proceedings papers

• Mohammedeid A, Bhargava A, Godena VK, Kong S, Tennore R, Grierson AJ, Xu J, Shaw PJ, Azzouz M & Ning K (2019) Arfaptin-2 as a therapeutic target for amyotrophic lateral sclerosis (ALS). HUMAN GENE THERAPY, Vol. 30(8) (pp A19-A20)
• Hewamadduma C, Grierson A, Higginbottom A & Shaw P (2015) . Journal of the Neurological Sciences, Vol. 357 (pp e49-e49)
• Adamson KI & Grierson AJ (2015) FISH ON DRUGS: A ZEBRAFISH PRECLINICAL MODEL FOR CMT2A. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, Vol. 20(2) (pp 92-93)
• Mohammedeid A, Ning K, Kong SC, Azzouz M & Grierson A (2014) Regulation of protein aggregation by Arfaptin2 in amyotrophic lateral sclerosis. HUMAN GENE THERAPY, Vol. 25(5) (pp A14-A14)
• Hewamadduma C, Grierson A, Moens C, Pan L, Ma T, Ingham P, Ramesh T & Shaw P (2012) A novel alternative splicing event rescues the mutant tardbp phenotype in a zebrafish model of TDP-43 related Amyotrophic Lateral Sclerosis (ALS). NEUROLOGY, Vol. 78
• Hewamadduma C, Grierson A, Moens C, Pan L, Ma T, Ingham P, Ramesh T & Shaw P (2012) A novel alternative splicing event rescues the mutant tardbp phenotype in a zebrafish model of TDP-43 related Amyotrophic Lateral Sclerosis (ALS). NEUROLOGY, Vol. 78
• Hewamadduma C, Higgenbottom CAA, Moens C, Helde K, Raman R, Tennore R, Grierson A & Shaw PJ (2012) . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 83(3)
• Eckmann J, Eckert SH, Leuner K, Bordet T, Pruss R, Grierson A, Shaw P, Clemens L, Nguyen HP, Mueller WE & Eckert GP (2011) Impact of Olesoxime on disease related mitochondrial membrane properties in mouse models of neurodegenerative diseases. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, Vol. 383 (pp 51-51)
• Valori CF, Ning K, Wyles M, Mead RJ, Grierson AJ, Shaw PJ & Azzouz M (2010) Systemic delivery of scAAV9 expressing SMN prolongs survival in a mouse model of SMA. HUMAN GENE THERAPY, Vol. 21(10) (pp 1424-1425)
• Clemens LE, Grierson A, De Vos K, Riess O & Nguyen HP (2010) . JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 81 (pp A5-A5)
• Sathasivam S, Grierson AJ & Shaw PJ (2005) Alterations of the Bcl-2 family oncoprotein members in a cell culture model of familial SOD1-related motor neurone disease. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 76(1) (pp 157-157)
• McDermott CJ, Grierson A, Wood J & Shaw PJ (2003) Hereditary spastic paraparesis associated with mutation in spastin (SPG4): A disorder of axonal transport?. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 74(10) (pp 1453-1453)

Preprints

• Butler L, Adamson KI, Johnson SL, Jestice LH, Price CJ, Stavish D, Pooranachandran N, Malicki JJ, Tsakiridis A, Grierson AJ & Barbaric I () , Cold Spring Harbor Laboratory.
• Marchi PM, Marrone L, Brasseur L, Bousset L, Webster CP, Destro M, Smith EF, Walther CG, Alfred V, Marroccella R , Robinson D et al () , Cold Spring Harbor Laboratory.
• Magoon GR, Banks RH, Rottensteiner C, Schrack BE, Tilroe VO, Robb T & Grierson AJ () , Cold Spring Harbor Laboratory.